Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02831335 · ClinicalTrials.gov registry record

Technical Development of Multi-Parametric Renocerebral MRI

A clinical trial of Aging, sponsored by University of Minnesota.

Recruiting
Registry status
120
Enrollment target
1
Study location

NCT02831335: Recruiting study of Aging, sponsored by University of Minnesota.

NCT02831335 is a study of Aging that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 120 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02831335, a study of Aging, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and functional MRI methods along with a battery of cognitive tests.

Primary Outcome

MRI measurements will be summarized for each group by using mean and standard deviation or standard error.

Conditions Studied

Interventions

  • OTHER MRI
  • OTHER Group 4

Study Locations (1)

Minnesota

  • Center for Magnetic Resonance Research - Minneapolis

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2026-12-01
Est. Completion 2032-12-31
University of Minnesota

966 total trials

What NCT02831335 shows while recruiting

NCT02831335 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.

NCT02831335 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02831335 about?

NCT02831335 is a clinical study titled "Technical Development of Multi-Parametric Renocerebral MRI". The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and functional MRI methods along with a battery of cognitive tests.

What is the current status of trial NCT02831335?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2026-12-01. Estimated completion is 2032-12-31.

What conditions does trial NCT02831335 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT02831335?

The interventions under investigation include: MRI (OTHER), Group 4 (OTHER).

Who is sponsoring clinical trial NCT02831335?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02831335 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02831335's enrollment target sits among peer trials

120 70th of 262 higher than 188 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02831335, the US trial registry maintained by the National Library of Medicine. NCT02831335 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.